Regulation of CAR T cell-mediated cytokine release syndrome-like toxicity using low molecular weight adapters
Chimeric antigen receptor (CAR) T cell anti-cancer therapies might result in toxic side effects. Here the authors present a strategy based on the modulation of CAR T cells via administration of a bispecific adapter that target them to cancer cells, resulting in diminished CAR-T cells toxicity and en...
Guardado en:
Autores principales: | Yong Gu Lee, Haiyan Chu, Yingjuan Lu, Christopher P. Leamon, Madduri Srinivasarao, Karson S. Putt, Philip S. Low |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/553694276e0c432681cac75ecb3328c9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies
por: Xinyi Xiao, et al.
Publicado: (2021) -
CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity
por: Wenyan Fu, et al.
Publicado: (2019) -
A universal dual mechanism immunotherapy for the treatment of influenza virus infections
por: Xin Liu, et al.
Publicado: (2020) -
Car braking effectiveness after adaptation for drivers with motor dysfunctions
por: Sowiński Adam, et al.
Publicado: (2021) -
Car braking effectiveness after adaptation for drivers with motor dysfunctions
por: Sowiński Adam, et al.
Publicado: (2021)